XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
MirraXinic™ is an AI-enabled PBPK model prediction platform that simulates the pharmacokinetics of intravenous and oral administration in animals and humans. It supports PK prediction of a single compound, the impact of drug-drug interaction analysis on PK performance, FIH prediction of the first dose in humans, PK derivation between different species, and other scenarios. Versions: V1.2
showing 1 - 1